http://www.thinkipstrategy.com/ipthinktank/316/pharmaceutical-polymorphs-and-patent-strategy/ Trusted advisors to the world's most innovative companies Mon, 16 Jan 2012 09:10:00 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://www.thinkipstrategy.com/ipthinktank/316/pharmaceutical-polymorphs-and-patent-strategy/comment-page-1/#comment-2568 Kmsenthil Mon, 07 Feb 2011 07:16:00 +0000 http://localhost:100/thinkipstrategy/?p=316#comment-2568 Section 3(d) is aimed at forbidding evergreening of the patents. US patentability jurisprudence envisages patenting anything under the sun. However, such criteria for patentability is leading to evergreening of the patents and hence monopoly of the patent system. Section 3d is one such provision which prevents the same. K.M.Senthil Kumar Section 3(d) is aimed at forbidding evergreening of the patents. US patentability jurisprudence envisages patenting anything under the sun. However, such criteria for patentability is leading to evergreening of the patents and hence monopoly of the patent system. Section 3d is one such provision which prevents the same. K.M.Senthil Kumar

]]>